Stelara 45/90 Mg 45mg. 90mg. Solution for Injection
PDF Leaflet Revision Date: 13 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Moderate to severe plaque psoriasis, psoriatic arthritis, Crohnu2019s disease, and ulcerative colitis.
Dosage (summary)
Adults: 45 mg SC at Weeks 0 and 4, then every 12 weeks; 90 mg for >100 kg. Pediatric: 0.75 mg/kg for <60 kg, 45 mg for 60-100 kg, 90 mg for >100 kg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; minimal excretion in breast milk.
Key Drug Interactions
- Live vaccines
- Immunosuppressants
Contraindications
- Hypersensitivity to ustekinumab
- Active tuberculosis
Common side effects
- Nasopharyngitis
- Headache
- Injection site reactions
Counselling Points
- Monitor for signs of infection
- Avoid live vaccines
- Report any serious allergic reactions
Serious warnings
- Increased risk of infections
- Serious hypersensitivity reactions
- Potential for malignancies
Important Disclaimer
The Stelara 45/90 Mg 45mg. 90mg. Solution for Injection professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
